ArticleEJHaem2021

A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cells.

Martin Grundy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.